Pielen A - Search Results

1

Efficacy and safety of intravitreal therapy in macular edema due to branch and central retinal vein occlusion: a systematic review.

Pielen A, Feltgen N, Isserstedt C, Callizo J, Junker B, Schmucker C. Pielen A, et al. PLoS One. 2013 Oct 25;8(10):e78538. doi: 10.1371/journal.pone.0078538. eCollection 2013. PLoS One. 2013. PMID: 24205253 Free PMC article. Review.

2

[Perioperative conversion of oral anticoagulants to heparin (bridging) in ophthalmic medicine].

Feltgen N, Pielen A, Hattenbach LO, Geisen U, Heinz J. Feltgen N, et al. Among authors: pielen a. Ophthalmologe. 2010 Jul;107(7):636-40. doi: 10.1007/s00347-009-2088-9. Ophthalmologe. 2010. PMID: 20024560 German.

3

[Intravitreal drug therapy for retinal vein occlusion--pathophysiological mechanisms and routinely used drugs].

Feltgen N, Pielen A, Hansen L, Bertram B, Agostini H, Jaissle GB, Hoerauf H, Stahl A. Feltgen N, et al. Among authors: pielen a. Klin Monbl Augenheilkd. 2010 Sep;227(9):681-93. doi: 10.1055/s-0029-1245606. Epub 2010 Sep 15. Klin Monbl Augenheilkd. 2010. PMID: 20845248 Review. German.

4

[Clinical diagnostics and therapy for non-arteritic central retinal artery occlusion].

Pielen A, Junker B, Hansen L, Agostini H, Feltgen N. Pielen A, et al. Klin Monbl Augenheilkd. 2010 Sep;227(9):712-20. doi: 10.1055/s-0029-1245660. Epub 2010 Sep 15. Klin Monbl Augenheilkd. 2010. PMID: 20845251 Review. German.

5

Predictive factors for functional improvement after intravitreal bevacizumab therapy for macular edema due to branch retinal vein occlusion.

Jaissle GB, Szurman P, Feltgen N, Spitzer B, Pielen A, Rehak M, Spital G, Heimann H, Meyer CH; Retinal Vein Occlusion Study Group. Jaissle GB, et al. Among authors: pielen a. Graefes Arch Clin Exp Ophthalmol. 2011 Feb;249(2):183-92. doi: 10.1007/s00417-010-1470-2. Epub 2010 Aug 18. Graefes Arch Clin Exp Ophthalmol. 2011. PMID: 21337042 Free PMC article.

6

[Ocular ischemic syndrome].

Pielen A, Junker B, Goldammer L, Schumacher M, Feltgen N. Pielen A, et al. Ophthalmologe. 2011 Mar;108(3):283-94; quiz 295. doi: 10.1007/s00347-010-2322-5. Ophthalmologe. 2011. PMID: 21424421 German.

7

Levels of VEGF but not VEGF(165b) are increased in the vitreous of patients with retinal vein occlusion.

Ehlken C, Rennel ES, Michels D, Grundel B, Pielen A, Junker B, Stahl A, Hansen LL, Feltgen N, Agostini HT, Martin G. Ehlken C, et al. Among authors: pielen a. Am J Ophthalmol. 2011 Aug;152(2):298-303.e1. doi: 10.1016/j.ajo.2011.01.040. Epub 2011 May 28. Am J Ophthalmol. 2011. PMID: 21621189

8

Bilateral serous retinal detachment.

Gundlach E, Junker B, Gross N, Hansen LL, Pielen A. Gundlach E, et al. Among authors: pielen a. Br J Ophthalmol. 2013 Jul;97(7):939-40, 949. doi: 10.1136/bjophthalmol-2012-302528. Epub 2013 Apr 23. Br J Ophthalmol. 2013. PMID: 23613507 No abstract available.

9

Intra- and postoperative risks and complications of small-gauge (23-G) versus conventional (20-G) vitrectomy for macular surgery.

Pielen A, Guerra NI, Böhringer D, Junker B, Bühler AD, Stahl A, Agostini HT, Ehlken C. Pielen A, et al. Eur J Ophthalmol. 2014 Sep-Oct;24(5):778-85. doi: 10.5301/ejo.5000461. Epub 2014 Mar 24. Eur J Ophthalmol. 2014. PMID: 24706351

10

Switch of anti-VEGF agents is an option for nonresponders in the treatment of AMD.

Ehlken C, Jungmann S, Böhringer D, Agostini HT, Junker B, Pielen A. Ehlken C, et al. Among authors: pielen a. Eye (Lond). 2014 May;28(5):538-45. doi: 10.1038/eye.2014.64. Epub 2014 Apr 11. Eye (Lond). 2014. PMID: 24722504 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

77 results

Search Page